The FDA Circulatory System Devices Panel met on June 12, 2018 to provide advice, make recommendations, and vote on the premarket approval application by Cordis for its INCRAFT Stent Graft System. DRG Medtech Analyst Aditi Chadha has weighed in on this conversation to provide insight on Cordis’ current place in the market and what a positive decision means for the industry.



DRG becomes Clarivate

View Now